Equity Overview
Price & Market Data
Price: $0.123
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $7,157,753
Daily Volume: 0
Performance Metrics
1 Week: 7.30%
1 Month: 20.27%
3 Months: 21.34%
6 Months: -21.03%
1 Year: 42.82%
YTD: 21.34%
Details
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.